ARRIVENT
LIVE

Serial Number

98228980

Owner

ArriVent BioPharma, Inc.

Attorney

Wade Savoy

First Use Date

Oct 26, 2021

Filing Date

Oct 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ARRIVENT Trademark

Serial Number: 98228980 • Registration: 7877640

ARRIVENT is a trademark filed by ArriVent BioPharma, Inc. on October 18, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ArriVent BioPharma, Inc. (6 trademarks)

18 Campus Blvd., Suite 100
Newtown Square, PA 19073-3269

Entity Type: 03

Trademark Details

Filing Date

October 18, 2023

Registration Date

August 5, 2025

First Use Anywhere

October 26, 2021

First Use in Commerce

October 26, 2021

Published for Opposition

December 31, 2024

Goods & Services

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer

research and development in the pharmaceutical and biotechnology fields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 10, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 30, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2024 CNSA
USE AMENDMENT ACCEPTED
Dec 5, 2024 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Dec 4, 2024 AUPC
USE AMENDMENT FILED
Dec 4, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 4, 2024 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 15, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 15, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2023 NWOS
NEW APPLICATION ENTERED
Oct 21, 2023 NWAP